Advertisement
UK markets open in 6 hours 35 minutes
  • NIKKEI 225

    37,722.76
    -239.04 (-0.63%)
     
  • HANG SENG

    16,251.84
    +2.87 (+0.02%)
     
  • CRUDE OIL

    82.80
    +0.11 (+0.13%)
     
  • GOLD FUTURES

    2,382.50
    -5.90 (-0.25%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • Bitcoin GBP

    49,073.81
    -2,216.60 (-4.32%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    15,683.37
    -181.88 (-1.15%)
     
  • UK FTSE All Share

    4,273.02
    +12.61 (+0.30%)
     

Global Real World Evidence Solutions Market to Reach US$1.9 Billion by the Year 2027

Dublin, Dec. 31, 2020 (GLOBE NEWSWIRE) -- The "Real World Evidence Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Real World Evidence Solutions estimated at US$770.8 Million in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 13.7% over the period 2020-2027. Data Sets, one of the segments analyzed in the report, is projected to grow at a 14.3% CAGR to reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 12.4% CAGR for the next 7-year period. This segment currently accounts for a 32% share of the global Real World Evidence Solutions market.

The U. S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 13.2% CAGR for the Period of 2020-2027

The Real World Evidence Solutions market in the U. S. is estimated at US$227.8 Million in the year 2020. The country currently accounts for a 29.55% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$329.8 Million in the year 2027 trailing a CAGR of 13.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR while the Rest of European market (as defined in the study) will reach US$329.8 Million by the year 2027.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • Anthem, Inc.

  • Clinigen Group Plc

  • Cognizant Technology Solutions Corporation

  • IBM Corporation

  • ICON PLC

  • IQVIA

  • Optum, Inc.

  • Oracle Corporation

  • Parexel International Corporation

  • PerkinElmer, Inc.

  • Pharmaceutical Product Development LLC

  • SAS Institute, Inc.

  • Syneos Health

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession

  • Global Competitor Market Shares

  • Real World Evidence Solutions Competitor Market Share Scenario Worldwide (in %): 2018E

ADVERTISEMENT

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/w1o86f

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900